Zentralbl Chir 2001; 126(Supplement I): 9-13
DOI: 10.1055/s-2001-19190
Originalarbeit

J.A.Barth Verlag in Medizinverlage Heidelberg GmbH & Co.KG

Distale Ösophagusresektion und Dünndarminterposition beim Frühkarzinom im Barrett-Ösophagus

Distal esophageal resection and jejunum interposition for early Barrett carcinomaH. J. Stein, M. Feith, J. R. Siewert
  • Chirurgische Klinik und Poliklinik (Direktor: Prof. Dr. J.R. Siewert), Klinikum rechts der Isar der Technischen Universität München
Further Information

Publication History

Publication Date:
20 December 2001 (online)

Distal esophageal resection and jejunum interposition for early Barrett carcinoma

Summary

Limited resection with regional lymphadenectomy and jejunal interposition is safe, prevents gastroesophageal reflux and is associated with good quality of life. The procedure represents an oncologically adequate and thus attractive limited surgical alternative to radical esophagectomy or endoscopic resection and ablation techniques in patients with high grade dysplasia or T1 adenocarcinoma in Barrett's esophagus.

Zusammenfassung

Eine limitierte Resektion des distalen Ösophagus und ösophagogastralen Übergangs mit regionaler Lymphadenektomie stellt eine onkologisch adäquate chirurgische Alternative zur radikalen Ösophagektomie oder endoskopischen Mukosaresektion bei Patienten mit hochgradiger Dysplasie oder T1-Karzinom im Barrett-Ösophagus dar. Rekonstruktion mittels Interposition eines gestielten isoperistaltischen Jejunumsegments ist sicher, verhindert gastro-ösophagealen Reflux und resultiert in einer guten Lebensqualität.

Literatur

  • 1 Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, Henrich R, Vieth M, Müller H, Seitz G, Stolte M. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus.  Gastroenterology. 2000;  118 670-677
  • 2 Eypasch E P, Williams J I, Wood-Dauphinee S, Ure B M, Schmülling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument.  Br J Surg. 1995;  82 216-222
  • 3 Gossner L, May A, Stolte M, Seitz G, Hahn E G, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.  Gastrointest Endosc. 1999;  49 8-12
  • 4 Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn E G, Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
  • 5 Hagen J A, Peters J H, DeMeester T R. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.  J Thorac Cardiovasc Surg. 1993;  106 850-859
  • 6 Hölscher A H, Bollschweiler E, Schneider P M, Siewert J R. Early adenocarcinoma in Barrett's oesophagus.  Br J Surg. 1997;  84 1470-1473
  • 7 Kirby J D. Quality of life after oesophagectomy: the patients' perspective.  Dis Esophagus. 1999;  12 168-171
  • 8 Merendino K A, Dillard D H. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiological abnormalities at the esophagogastric junction.  Ann Surg. 1955;  142 486-506
  • 9 Nigro J J, Hagen J A, DeMeester T R, DeMeester S R, Peters J H, Oberg S, Theisen J, Kiyabu M, Crookes P F, Bremner C. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy.  J Thorac Cardiovasc Surg. 1999;  117 16-23
  • 10 Nigro J J, Hagen J A, DeMeester T R, DeMeester S R, Theisen J, Peters J H, Kiyabu M. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy.  Ann Surg. 1999;  230 433-438
  • 11 Riben M, Ilves R, McKenna B J. Second primary Barrett's adenocarcinoma after 19 years.  Ann Thorac Surg. 1999;  67 1796-1798
  • 12 Rusch V W, Levine D S, Haggitt R, Reid B J. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.  Cancer. 1994;  74 1225-1229
  • 13 Sharma P, Jaffe P E, Bhattacharyya A, Sampliner R E. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up.  Gastrointest Endosc. 1999;  49 442-446
  • 14 Siewert J R, Stein H J. Barrett's cancer: Indications, extent and results of surgical resection.  Sem Surg Oncol. 1997;  13 245-252
  • 15 Siewert J R, Stein H J. Lymphadenectomy for esophageal cancer.  Langenbecks Arch Surg. 1999;  384 141-148
  • 16 Sobin L H, Wittekind C. International Union Against Cancer (UICC) (eds) .TNM classification of malignant tumors. 5th edn. Wiley & Sons 1997
  • 17 Stein H J, Feith M, Feussner H. The relationship between gastroesophageal reflux, development of Barrett's epithelium and cancer of the esophagus.  Langenbecks Arch Surg. 2000;  385 309-316
  • 18 Stein H J, Feith M, Siewert J R. Malignant degeneration of Barrett's esophagus. Clinical point of view.  Rec Res Canc Res. 2000;  155 119-122
  • 19 Stein H J, Feith M, Müller J, Werner M, Siewert J R. Limited resection for early Barrett's cancer.  Ann Surg. 2000;  232 733-742
  • 20 van Sandick J W, van Lanschot J J, Kuiken B W, Tytgat G N, Offerhaus G J, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.  Gut. 1998;  43 216-222
  • 21 Wright C, Cuschieri A. Jejunal interposition for benign esophageal disease. Technical considerations and long-term results.  Ann Surg. 1987;  205 54-60

Priv.-Doz. Dr. Hubert J. Stein

Chirurgische Klinik und Poliklinik
Klinikum rechts der Isar der TU München

Ismaningerstraße 22

D-81675 München

Phone: 0 89/41 40 47 45

Fax: 0 89/41 40 49 40

Email: stein@nt1.chir.med.tu-muenchen.de

    >